Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 4, 2010, Pages 2095-2099

  Gota, Vikram S ^a   Maru, Girish B ^a   Soni, Tejal G ^b   Gandhi, Tejal R ^b   Nltin Kochar, ^a,b,c   Agarwal, Manish G ^a  

^a TATA MEMORIAL HOSPITAL   (India)

^b ANAND PHARMACY COLLEGE   (India)

^c KEM HOSPITAL   (India)

Author keywords

Bioavailability; Curcuma longa; Osteosarcoma; Pharmacokinetics; Safety; Solid lipid curcumin particle

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN;

ADOLESCENT; ADULT; ARTICLE; BONE TUMOR; CHEMISTRY; CHILD; CURCUMA LONGA; DRUG TOLERANCE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; OSTEOSARCOMA; REFERENCE VALUE; SAFETY;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHEMISTRY, PHARMACEUTICAL; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CURCUMA; CURCUMIN; DRUG TOLERANCE; FEMALE; HUMANS; MALE; OSTEOSARCOMA; REFERENCE VALUES; SAFETY; YOUNG ADULT;

CURCUMA LONGA;

EID: 77249131774     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf9024807     Document Type: Article

References (24)

1. Tayyem, R.; Heath, D.; Al-Delaimy, W.; Rock, C. Curcumin content of turmeric and curry powders. Nutr, Cancer 2006, 55 (2), 126-131. (Pubitemid 44719625)
2. Aggarwal, B.; Kumar, A.; Bharti, A. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003, 23 (1A), 363-398. (Pubitemid 36361976)
3. Kuttan, R.; Bhanumathy, P.; Nirmala, K.; George, M. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 1985, 29 (2), 197-202.
4. Shishodia, S.; Singh, T.; Chaturvedi, M. Modulation of transcription factors by curcumin. Adv. Exp. Med. Biol. 2007, 595, 127-148.
5. Aggarwal, B.; Bhatt, I.; Ichikawa, H.; Ahn, K.; Sethi, G.; Sandur, S. Curcumin-boiological and medicinal properties. In Turmeric: the Genus Curcuma; Ravindran, P., Babu, N., Sivaraman, K., Eds.; Taylor and Francis Group: Boca Raton, FL, 2007; Vol.1, pp 297-368.
6. Fagioli, F.; Biasin, E.; Mereuta, O. M.; Muraro, M.; Luksch, R.; Ferrari, S.; Aglietta, M.; Madon, E. Poor prognosis osteosarcoma: new therapeutic approach. Bone Marrow Transplant, 2008, 41 (Suppl. 2), S131-S134.
7. Walters, D.; Muff, R.; Langsam, B.; Born, W.; Fuchs, B. Cytotoxic effects of curcumin on osteosarcoma cell lines. Invest. New Drugs 2008, 26 (4), 289-297.
8. López-Lázaro, M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol. Nutr. Food Res. 2008, 52 (Suppl. 1), S103-S127.
9. Dujic, J.; Kippenberger, S.; Ramirez-Bosca, A.; Diaz-Alperi, J.; Bereiter-Hahn, J.; Kaufmann, R.; Bernd, A.; Hofmann, M. Curcumin in combination with visible light inhibits tumor growth, in a xenograft tumor model. Int. J. Cancer 2009, 124 (6), 1422-1428.
10. Sung, B.; Kunnumakkara, A.; Sethi, G.; Anand, P.; Guha, S.; Aggarwal, B. Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. Mol. Cancer Ther. 2009, 8 (4), 959-970.
11. Lao, C.; Ruffin, M.IV; Normolle, D.; Heath, D.; Murray, S.; Bailey, J. Dose escalation of a curcuminoid formulation. BMC Complement. Altern. Med. 2006, 6-10.
12. Dhillon, N.; Aggarwal, B.; Newman, R.; Wolff, R.; Kunnumakkara, A.; Abbruzzese, J.; Ng, C.; Badmaev, V.; Kurzrock, R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 2008, 14 (14), 4491-4499.
13. Sharma, R. A.; Euden, S. A.; Platten, S. L.; Cooke, D. N.; Shafayat, A.; Hewitt, H. R.; Marczylo, T. H.; Morgan, B.; Hemingway, D.; Plummer, S. M. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer Res. 2004, 10, 6847-6854.
14. Sharma, R.; McLelland, H.; Hill, K.; Ireson, C.; Euden, S.; Manson, M.; Pirmohamed, M.; Marnett, L.; Gescher, A.; Steward, W. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 2001, 7, 894-900.
15. Asai, A.; Miyazawa, T. Occurrence of orally administered curcuminoid glucuronide and glucuronide/ sulfate conjugates in rat plasma. Life Sci. 2000, 67, 2785-2793.
16. Ono, K.; Hasegawa, K.; Naiki, H.; Yamada, M. Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro. J. Neurosci. Res. 2004, 75 (6), 742-750. (Pubitemid 38296087)
17. Frautschy, S.; Begum, A.; Teng, E.; Rosario, E.; Teter, B.; Faull, K.; Cole, G. Improving bioavailability of curcumin by solid lipid particle for treatment of Alzheimer's (AD) [abstract]. Program 11.8. 2008; Neuroscience Meeting Planner; Society for Neuroscience Washington, DC, 2008, http://www.abstractsonline.com/Plan/ViewAbstract.aspx? sKey=21bdlccb-f3cd-4f92- bf97-d456539d0943&cKey=dfa2a8de-663c45dd-9cl.8-2f4927ea2b20.
18. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). http://ctep.cancer.gov/protocoIDevelopment/electronic-app.lications/docs/ ctcaev3.pdf (accessed July 14, 2009).
19. Aggarwal, B.; Sundaram, C.; Malani, N.; Ichikawa, H. Curcumin: the Indian, solid gold. Adv. Exp. Med. Biol. 2007, 595, 1-75.
20. Maiti, K.; Mukherjee, K.; Gantait, A.; Saha, B.; Mukherjee, P. Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm. 2007, 330 (1-2), 155-163. (Pubitemid 46097368)
21. Marczylo, T.; Verschoyle, R.; Cooke, D.; Morazzoni, P.; Steward, W.; Gescher, A. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother. Pharmacol. 2007, 60, 171-177. (Pubitemid 46742531)
22. Liu, A.; Lou, H.; Zhao, L.; Fan, P. Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. J. Pharm. Biomed. Anal. 2006, 40, 720-727. (Pubitemid 43227396)
23. Vareed, S. K.; Kakarala, M.; Ruffin, M. T.; Crowell J. A.; Normolle, D. P.; Djuric, Z.; Brenner, D. E. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Enidemiol. Biomarkers Prev. 2008, 77(6), 1411-1417.
24. Yadav, V.; Suresh, S.; Devi, K.; Yadav, S. Novel formulation of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy for inflammatory bowel disease. J. Pharm. Phrmacol. 2009, 61 (3), 311-321,